Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Tevogen Bio (TVGN)

Tevogen Bio Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TVGN
DateTimeSourceHeadlineSymbolCompany
10/05/202422:40GlobeNewswire Inc.Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational ObjectivesNASDAQ:TVGNTevogen Bio Holdings Inc
01/05/202413:05GlobeNewswire Inc.Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational ObjectivesNASDAQ:TVGNTevogen Bio Holdings Inc
26/04/202414:23GlobeNewswire Inc.Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership AppointmentsNASDAQ:TVGNTevogen Bio Holdings Inc
11/04/202413:05GlobeNewswire Inc.Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target CancersNASDAQ:TVGNTevogen Bio Holdings Inc
03/04/202413:05GlobeNewswire Inc.Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate DevelopmentNASDAQ:TVGNTevogen Bio Holdings Inc
28/03/202412:05GlobeNewswire Inc.Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion PriceNASDAQ:TVGNTevogen Bio Holdings Inc
20/03/202411:00Business WireTevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 VariantNASDAQ:TVGNTevogen Bio Holdings Inc
05/03/202413:00Business WireTevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at VeritaNASDAQ:TVGNTevogen Bio Holdings Inc
04/03/202421:24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TVGNTevogen Bio Holdings Inc
27/02/202421:39Business WireMittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AINASDAQ:TVGNTevogen Bio Holdings Inc
23/02/202401:13Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TVGNTevogen Bio Holdings Inc
23/02/202401:09Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TVGNTevogen Bio Holdings Inc
21/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TVGNTevogen Bio Holdings Inc
21/02/202412:00Business WireCell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID TreatmentNASDAQ:TVGNTevogen Bio Holdings Inc
20/02/202413:57Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TVGNTevogen Bio Holdings Inc
17/02/202405:17Business WireCell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open MarketNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
16/02/202422:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TVGNTevogen Bio Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:TVGN